The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study
Abstract
Background Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation on incidence of Hib disease.Methods Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar.Findings Between May, 1997, and April, 2002, a total of 5984 children were examined for possible Hib infections. 49 children had Hib disease, 36 of whom had meningitis. The annual incidence rates of Hib meningitis before any use of the vaccine (1990-93) dropped from over 200 per 100,000 children aged younger than 1 year to none per 100,000 in 2002, and from 60 to no cases per 100,000 in children younger than 5 years. The prevalence of Hib carriage decreased from 12% to 0.25% (p<0.0001). Two doses of vaccine were needed for direct protection from Hib disease (vaccine efficacy 94%, 95% CI 62-99). Since most children received a protective dose after the age of greatest disease risk, indirect effects were important in reducing disease incidence.Interpretation The Gambian Hib immunisation programme reduced the occurrence of Hib disease despite irregular vaccine supply. The effect of the programme in The Gambia has important implications for the introduction of the vaccine into routine immunisation programmes of other developing countries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In other developing countries, the overall vaccine efficacy rate has ranged from 88 to 94% (Table 1) (3, 78, 83, 122).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [3]
Citations
Cites
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Self-citationDecline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
Adams, W. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020055031 · Cited by 696
Mulholland, K., Hilton, S., Adegbola, R., Usen, S., Oparaugo, A., Omosigho, C., Weber, M., Palmer, A., Schneider, G., Jobe, K., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09267-7 · Cited by 406
Self-citationPeltola, H., Kilpi, T., Anttila, M., Peltola, H., & Kilpi, T. (1992) · The Lancet · doi:10.1016/0140-6736(92)92117-x · Cited by 344
Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines
Decker, M. D., Edwards, K. M., Bradley, R., & Palmer, P. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80424-x · Cited by 228
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
Comparison of two cluster sampling methods for health surveys in developing countries
Milligan, P. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh096 · Cited by 171
Self-citationGoetghebuer, T., West, T. E., Wermenbol, V., Cadbury, A. L., Milligan, P. J., LLOYD-EVANS, N., Adegbola, R. A., Mulholland, E. K., Greenwood, B. M., & Weber, M. W. (2000) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2000.00535.x · Cited by 115
Self-citationAdegbola, R. A., Mulholland, K., Secka, O., Jaffar, S. S., & Greenwood, B. M. (1998) · The Journal of Infectious Diseases · doi:10.1086/517440 · Cited by 96
Self-citationBULKOW, L. R., Wainwright, R. B., Letson, G. W., Chang, S.-J., & Ward, J. I. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199306000-00006 · Cited by 94
Research works printed but not linked: 1
- Gieseche, 1997, Increase in pneumococcal bacteremia in Sweden, Lancet, 349, 670
Cited by
The Meaning of Translational Research and Why It Matters
Woolf, S. H. (2008) · JAMA · doi:10.1001/jama.2007.26 · Cited by 1,910
Vaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
Wahl, B., O'Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukšić, I., Nair, H., McAllister, D. A., Campbell, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30247-x · Cited by 1,118
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“In other developing countries, the overall vaccine efficacy rate has ranged from 88 to 94% (Table 1) (3, 78, 83, 122).”
BackgroundWatt, J. P., Wolfson, L. J., O'Brien, K. L., Henkle, E., Deloria-Knoll, M., McCall, N., Lee, E., Levine, O. S., Hajjeh, R., Mulholland, K., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61203-4 · Cited by 501
Self-citation
Metadata
- Authors
- Adegbola, R. A., Secka, O., Lahai, G., Lloyd-Evans, N., Njie, A., Usen, S., Oluwalana, C., Obaro, S., Weber, M., Corrah, T., Mulholland, K., McAdam, K., Greenwood, B., & Milligan, P. J.
- Affiliations
- MRC Unit the Gambia (GM)
- Royal Children's Hospital (AU)
- London School of Hygiene & Tropical Medicine (GB)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 366
- Issue
- 9480
- Pages
- 144-150
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2113818521
- Cited by
- 286
- References
- 24
- Citations by year
- 2025: 5 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 13 · 2018: 11 · 2017: 8 · 2016: 13 · 2015: 14 · 2014: 22 · 2013: 19 · 2012: 16
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- Haemophilus influenzae type b, Hib conjugate vaccine, Hib meningitis, routine immunization, vaccine efficacy, disease elimination, indirect protection, Expanded Programme on Immunization, infant immunization, Gambia
- MeSH terms
- Child, Preschool, Developing Countries, Gambia, Haemophilus Infections, Humans, Infant, Meningitis, Haemophilus, Tetanus Toxoid, Incidence, Prevalence, Immunization Programs, Haemophilus Vaccines, Vaccines, Conjugate, Haemophilus influenzae type b
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. https://app.cochat.ai/papers/10.1016/s0140-6736(05)66788-8
- The paper
- Adegbola, R. A., Secka, O., Lahai, G., Lloyd-Evans, N., Njie, A., Usen, S., Oluwalana, C., Obaro, S., Weber, M., Corrah, T., Mulholland, K., McAdam, K., Greenwood, B., & Milligan, P. J. (2005). Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. The Lancet. https://doi.org/10.1016/s0140-6736(05)66788-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.